Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F H Messerli

Showing results (281-290 of 338) with videos related to

Pageof 34
Sort By:
The American Journal of Cardiology|January 1, 1984
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertensionF G Dunn, W Oigman, H O Ventura, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1975
Diurnal variation of plasma vasopressin in manC P George, F H Messerli, J Genest, et al.
JAMA|August 18, 1999
Diuretics for hypertensionF H Messerli, B D Nunez, M Nunez, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Systemic and renal effects of enalapril and its effects on cardiac massF G Dunn, W Oigman, H O Ventura, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1977
Response of several adrenal steroids to ACTH stimulation in essential hypertensionM Honda, W Nowaczynski, G P Guthrie, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Age- and posture-related changes in plasma protein binding and metabolism of aldosterone in essential and secondary hypertensionW Nowaczynski, J Genest, O Kuchel, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1984
Stable red cell mass despite contracted plasma volume in men with essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.
Clinical Pharmacology and Therapeutics|February 1, 1983
Hemodynamic effects of intravenous labetalol in essential hypertensionF G Dunn, W Oigman, F H Messerli, et al.
The American Journal of Cardiology|March 1, 1983
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertensionH O Ventura, F H Messerli, W Oigman, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1977
[Increased renal prostaglandin E2 secretion in Bartter's syndrome]H A Schwarz, P Weidmann, F H Messerli, et al.
Pageof 34

Showing results (281-290 of 338) with videos related to

Sort By:
Pageof 34
The American Journal of Cardiology|January 1, 1984
Enalapril improves systemic and renal hemodynamics and allows regression of left ventricular mass in essential hypertensionF G Dunn, W Oigman, H O Ventura, et al.
The Journal of Clinical Endocrinology and Metabolism|August 1, 1975
Diurnal variation of plasma vasopressin in manC P George, F H Messerli, J Genest, et al.
JAMA|August 18, 1999
Diuretics for hypertensionF H Messerli, B D Nunez, M Nunez, et al.
Journal of Hypertension. Supplement : Official Journal of the International Society of Hypertension|December 1, 1984
Systemic and renal effects of enalapril and its effects on cardiac massF G Dunn, W Oigman, H O Ventura, et al.
The Journal of Clinical Endocrinology and Metabolism|February 1, 1977
Response of several adrenal steroids to ACTH stimulation in essential hypertensionM Honda, W Nowaczynski, G P Guthrie, et al.
The Journal of Laboratory and Clinical Medicine|September 1, 1977
Age- and posture-related changes in plasma protein binding and metabolism of aldosterone in essential and secondary hypertensionW Nowaczynski, J Genest, O Kuchel, et al.
The Journal of Laboratory and Clinical Medicine|July 1, 1984
Stable red cell mass despite contracted plasma volume in men with essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.
Clinical Pharmacology and Therapeutics|February 1, 1983
Hemodynamic effects of intravenous labetalol in essential hypertensionF G Dunn, W Oigman, F H Messerli, et al.
The American Journal of Cardiology|March 1, 1983
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertensionH O Ventura, F H Messerli, W Oigman, et al.
Schweizerische Medizinische Wochenschrift|December 10, 1977
[Increased renal prostaglandin E2 secretion in Bartter's syndrome]H A Schwarz, P Weidmann, F H Messerli, et al.
Pageof 34